Editorial

Research studies

Editorial summaries of selected peptide research literature, written for a technically literate audience. Each note cites the underlying published studies.

• 2026.06.10Metabolic

  Long-term cardiovascular outcomes with GLP-1 agonism: a reading of SELECT follow-up data

  A summary of secondary endpoints reported in the SELECT cardiovascular outcomes trial, with attention to methodological caveats around dropout and unblinding.

  Read full note
• 2026.05.28Metabolic

  Tirzepatide and Retatrutide: a new generation of multi-receptor incretins

  A review of the published Phase 3 evidence for tirzepatide (SURPASS, SURMOUNT) and the Phase 2 results for retatrutide, highlighting the magnitude of weight loss, glycemic control, and emerging cardiometabolic benefits reported in peer-reviewed trials.

  Read full note